Stay updated on CP-690,550 Doses vs. Placebo in Arthritis Clinical Trial
Sign up to get notified when there's something new on the CP-690,550 Doses vs. Placebo in Arthritis Clinical Trial page.

Latest updates to the CP-690,550 Doses vs. Placebo in Arthritis Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedThe expected modernization date for the ClinicalTrials.gov data ingest has been updated from June 2025 to July 2025.SummaryDifference0.3%
- Check21 days agoNo Change Detected
- Check28 days agoChange DetectedThe web page has been updated from version 2.16.1 to version 2.16.2.SummaryDifference0.0%
- Check35 days agoChange DetectedThe web page has been updated to indicate that the ClinicalTrials.gov data ingest will be modernized in June 2025, allowing API users to provide input before implementation. Additionally, the revision number has been updated from v2.15.2 to v2.16.1.SummaryDifference0.5%
- Check42 days agoChange DetectedThe page has removed a citation regarding the characterization of creatine kinase levels in tofacitinib-treated patients with ulcerative colitis, including an erratum reference.SummaryDifference0.1%
- Check56 days agoChange DetectedThe page has removed a citation regarding the efficacy and safety of tofacitinib, including an erratum reference.SummaryDifference0.1%
- Check64 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.0%
Stay in the know with updates to CP-690,550 Doses vs. Placebo in Arthritis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CP-690,550 Doses vs. Placebo in Arthritis Clinical Trial page.